Stock Events

Stock Events

Atea Pharmaceuticals (AVIR) Q3 2024 Earnings

7AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.75

-0.63

-0.52

-0.4

Details

Expected EPS

-0.662932

Actual EPS

-0.48

Surprise EPS

0.18

Surprise Percent

+27.59%

Description

Atea Pharmaceuticals (AVIR) has reported earnings of -0.48 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.